AFP and hepatocellular carcinoma: Previous studies demonstrated that HCC patients are more likely to have T cells specific to AFP epitopes in the peripheral blood than healthy individuals and that the ratio of these T cells in the peripheral blood increases with cancer progression and after RFA and TACE [9, 23].